FDA approvals February 2026 BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2. FDA is moving them to an independent scientific FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not Innovative Biologics Expected Biologic Drug Approvals in 2026 Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. The FDA's Current Position on Peptides Explained Holt Law